Report cover image

Global Neuroimaging Software Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Jan 01, 2026
Length 194 Pages
SKU # APRC20817188

Description

The global Neuroimaging Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Neuroimaging Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Neuroimaging Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for Neuroimaging Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Neuroimaging Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Neuroimaging Software include IXICO, QMENTA, Cortechs.ai, Quantib, Brainomix, Qure.AI, Imaging Biometrics, LLC and A.I. Analysis, Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes



This report presents an overview of global market for Neuroimaging Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neuroimaging Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Neuroimaging Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neuroimaging Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neuroimaging Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Neuroimaging Software revenue, projected growth trends, production technology, application and end-user industry.

Neuroimaging Software Segment by Company

IXICO
QMENTA
Cortechs.ai
Quantib
Brainomix
Qure.AI
Imaging Biometrics, LLC
A.I. Analysis, Inc

Neuroimaging Software Segment by Type

Cloud-based
On Premise

Neuroimaging Software Segment by Application

Hospitals and Clinics
Diagnostic Imaging Centers
Ambulatory Surgical Centers

Neuroimaging Software Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuroimaging Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neuroimaging Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuroimaging Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Neuroimaging Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Neuroimaging Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neuroimaging Software revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Neuroimaging Software Market by Type
1.2.1 Global Neuroimaging Software Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 Cloud-based
1.2.3 On Premise
1.3 Neuroimaging Software Market by Application
1.3.1 Global Neuroimaging Software Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Imaging Centers
1.3.4 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Neuroimaging Software Market Dynamics
2.1 Neuroimaging Software Industry Trends
2.2 Neuroimaging Software Industry Drivers
2.3 Neuroimaging Software Industry Opportunities and Challenges
2.4 Neuroimaging Software Industry Restraints
3 Global Growth Perspective
3.1 Global Neuroimaging Software Market Perspective (2021-2032)
3.2 Global Neuroimaging Software Growth Trends by Region
3.2.1 Global Neuroimaging Software Market Size by Region: 2021 VS 2025 VS 2032
3.2.2 Global Neuroimaging Software Market Size by Region (2021-2026)
3.2.3 Global Neuroimaging Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
4.1 Global Neuroimaging Software Revenue by Players
4.1.1 Global Neuroimaging Software Revenue by Players (2021-2026)
4.1.2 Global Neuroimaging Software Revenue Market Share by Players (2021-2026)
4.1.3 Global Neuroimaging Software Players Revenue Share Top 10 and Top 5 in 2025
4.2 Global Neuroimaging Software Key Players Ranking, 2024 VS 2025 VS 2026
4.3 Global Neuroimaging Software Key Players Headquarters & Area Served
4.4 Global Neuroimaging Software Players, Product Type & Application
4.5 Global Neuroimaging Software Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Neuroimaging Software Market CR5 and HHI
4.6.3 2025 Neuroimaging Software Tier 1, Tier 2, and Tier 3
5 Neuroimaging Software Market Size by Type
5.1 Global Neuroimaging Software Revenue by Type (2021 VS 2025 VS 2032)
5.2 Global Neuroimaging Software Revenue by Type (2021-2032)
5.3 Global Neuroimaging Software Revenue Market Share by Type (2021-2032)
6 Neuroimaging Software Market Size by Application
6.1 Global Neuroimaging Software Revenue by Application (2021 VS 2025 VS 2032)
6.2 Global Neuroimaging Software Revenue by Application (2021-2032)
6.3 Global Neuroimaging Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
7.1 IXICO
7.1.1 IXICO Company Information
7.1.2 IXICO Business Overview
7.1.3 IXICO Neuroimaging Software Revenue and Gross Margin (2021-2026)
7.1.4 IXICO Neuroimaging Software Product Portfolio
7.1.5 IXICO Recent Developments
7.2 QMENTA
7.2.1 QMENTA Company Information
7.2.2 QMENTA Business Overview
7.2.3 QMENTA Neuroimaging Software Revenue and Gross Margin (2021-2026)
7.2.4 QMENTA Neuroimaging Software Product Portfolio
7.2.5 QMENTA Recent Developments
7.3 Cortechs.ai
7.3.1 Cortechs.ai Company Information
7.3.2 Cortechs.ai Business Overview
7.3.3 Cortechs.ai Neuroimaging Software Revenue and Gross Margin (2021-2026)
7.3.4 Cortechs.ai Neuroimaging Software Product Portfolio
7.3.5 Cortechs.ai Recent Developments
7.4 Quantib
7.4.1 Quantib Company Information
7.4.2 Quantib Business Overview
7.4.3 Quantib Neuroimaging Software Revenue and Gross Margin (2021-2026)
7.4.4 Quantib Neuroimaging Software Product Portfolio
7.4.5 Quantib Recent Developments
7.5 Brainomix
7.5.1 Brainomix Company Information
7.5.2 Brainomix Business Overview
7.5.3 Brainomix Neuroimaging Software Revenue and Gross Margin (2021-2026)
7.5.4 Brainomix Neuroimaging Software Product Portfolio
7.5.5 Brainomix Recent Developments
7.6 Qure.AI
7.6.1 Qure.AI Company Information
7.6.2 Qure.AI Business Overview
7.6.3 Qure.AI Neuroimaging Software Revenue and Gross Margin (2021-2026)
7.6.4 Qure.AI Neuroimaging Software Product Portfolio
7.6.5 Qure.AI Recent Developments
7.7 Imaging Biometrics, LLC
7.7.1 Imaging Biometrics, LLC Company Information
7.7.2 Imaging Biometrics, LLC Business Overview
7.7.3 Imaging Biometrics, LLC Neuroimaging Software Revenue and Gross Margin (2021-2026)
7.7.4 Imaging Biometrics, LLC Neuroimaging Software Product Portfolio
7.7.5 Imaging Biometrics, LLC Recent Developments
7.8 A.I. Analysis, Inc
7.8.1 A.I. Analysis, Inc Company Information
7.8.2 A.I. Analysis, Inc Business Overview
7.8.3 A.I. Analysis, Inc Neuroimaging Software Revenue and Gross Margin (2021-2026)
7.8.4 A.I. Analysis, Inc Neuroimaging Software Product Portfolio
7.8.5 A.I. Analysis, Inc Recent Developments
8 North America
8.1 North America Neuroimaging Software Revenue (2021-2032)
8.2 North America Neuroimaging Software Revenue by Type (2021-2032)
8.2.1 North America Neuroimaging Software Revenue by Type (2021-2026)
8.2.2 North America Neuroimaging Software Revenue by Type (2027-2032)
8.3 North America Neuroimaging Software Revenue Share by Type (2021-2032)
8.4 North America Neuroimaging Software Revenue by Application (2021-2032)
8.4.1 North America Neuroimaging Software Revenue by Application (2021-2026)
8.4.2 North America Neuroimaging Software Revenue by Application (2027-2032)
8.5 North America Neuroimaging Software Revenue Share by Application (2021-2032)
8.6 North America Neuroimaging Software Revenue by Country
8.6.1 North America Neuroimaging Software Revenue by Country (2021 VS 2025 VS 2032)
8.6.2 North America Neuroimaging Software Revenue by Country (2021-2026)
8.6.3 North America Neuroimaging Software Revenue by Country (2027-2032)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Neuroimaging Software Revenue (2021-2032)
9.2 Europe Neuroimaging Software Revenue by Type (2021-2032)
9.2.1 Europe Neuroimaging Software Revenue by Type (2021-2026)
9.2.2 Europe Neuroimaging Software Revenue by Type (2027-2032)
9.3 Europe Neuroimaging Software Revenue Share by Type (2021-2032)
9.4 Europe Neuroimaging Software Revenue by Application (2021-2032)
9.4.1 Europe Neuroimaging Software Revenue by Application (2021-2026)
9.4.2 Europe Neuroimaging Software Revenue by Application (2027-2032)
9.5 Europe Neuroimaging Software Revenue Share by Application (2021-2032)
9.6 Europe Neuroimaging Software Revenue by Country
9.6.1 Europe Neuroimaging Software Revenue by Country (2021 VS 2025 VS 2032)
9.6.2 Europe Neuroimaging Software Revenue by Country (2021-2026)
9.6.3 Europe Neuroimaging Software Revenue by Country (2027-2032)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Neuroimaging Software Revenue (2021-2032)
10.2 China Neuroimaging Software Revenue by Type (2021-2032)
10.2.1 China Neuroimaging Software Revenue by Type (2021-2026)
10.2.2 China Neuroimaging Software Revenue by Type (2027-2032)
10.3 China Neuroimaging Software Revenue Share by Type (2021-2032)
10.4 China Neuroimaging Software Revenue by Application (2021-2032)
10.4.1 China Neuroimaging Software Revenue by Application (2021-2026)
10.4.2 China Neuroimaging Software Revenue by Application (2027-2032)
10.5 China Neuroimaging Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia Neuroimaging Software Revenue (2021-2032)
11.2 Asia Neuroimaging Software Revenue by Type (2021-2032)
11.2.1 Asia Neuroimaging Software Revenue by Type (2021-2026)
11.2.2 Asia Neuroimaging Software Revenue by Type (2027-2032)
11.3 Asia Neuroimaging Software Revenue Share by Type (2021-2032)
11.4 Asia Neuroimaging Software Revenue by Application (2021-2032)
11.4.1 Asia Neuroimaging Software Revenue by Application (2021-2026)
11.4.2 Asia Neuroimaging Software Revenue by Application (2027-2032)
11.5 Asia Neuroimaging Software Revenue Share by Application (2021-2032)
11.6 Asia Neuroimaging Software Revenue by Country
11.6.1 Asia Neuroimaging Software Revenue by Country (2021 VS 2025 VS 2032)
11.6.2 Asia Neuroimaging Software Revenue by Country (2021-2026)
11.6.3 Asia Neuroimaging Software Revenue by Country (2027-2032)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Neuroimaging Software Revenue (2021-2032)
12.2 SAMEA Neuroimaging Software Revenue by Type (2021-2032)
12.2.1 SAMEA Neuroimaging Software Revenue by Type (2021-2026)
12.2.2 SAMEA Neuroimaging Software Revenue by Type (2027-2032)
12.3 SAMEA Neuroimaging Software Revenue Share by Type (2021-2032)
12.4 SAMEA Neuroimaging Software Revenue by Application (2021-2032)
12.4.1 SAMEA Neuroimaging Software Revenue by Application (2021-2026)
12.4.2 SAMEA Neuroimaging Software Revenue by Application (2027-2032)
12.5 SAMEA Neuroimaging Software Revenue Share by Application (2021-2032)
12.6 SAMEA Neuroimaging Software Revenue by Country
12.6.1 SAMEA Neuroimaging Software Revenue by Country (2021 VS 2025 VS 2032)
12.6.2 SAMEA Neuroimaging Software Revenue by Country (2021-2026)
12.6.3 SAMEA Neuroimaging Software Revenue by Country (2027-2032)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.